ClinicalTrials.gg
Sign In

Hepatitis B, Chronic clinical trials

The registry lists 895 studies for Hepatitis B, Chronic across more than 10 countries. 151 are recruiting or about to start. 842 of them are mainly about Hepatitis B, Chronic (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06.

ClinicalTrials.gov finds 1,210 studies for Hepatitis B, Chronic. How that becomes 895 here

This page counts the studies the registry files under Hepatitis B, Chronic, and those it files under no condition that list Hepatitis B, Chronicthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 1,210Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −16List Hepatitis B, Chronic as a condition, but the registry did not file them under itMost often written as “Hepatitis B, Chronic (CHB)” (3), “Hepatitis B Chronic Infection” (2), and “HBe Negative Chronic Hepatitis B” (1). The registry filed them under other conditions only, most often Hepatitis B (11) and Bronchiolitis Obliterans Syndrome (4).
  3. −299Match it another way167 name it in the title, 3 in a keyword, and 129 by a synonym or other text the search reads.
  4. 895The count on this page30 of them list Hepatitis B, Chronic in their own words; the registry filed them under no condition.

Get an email when these change. Save the Hepatitis B, Chronic studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
407
Status unknown
210
Recruiting
96
Terminated
61
Not yet recruiting
49
Active, not recruiting
42

Phase

Phase 4
197
Phase 2
194
Phase 1
151
Phase 3
89
Early Phase 1
7

Where

China
374
Korea, Republic of
149
United States
112
Taiwan
99
Hong Kong
88
New Zealand
82

Who runs them

Hoffmann-La Roche (46) · Gilead Sciences (34) · Third Affiliated Hospital, Sun Yat-Sen University (29) · GlaxoSmithKline (28) · Beijing Ditan Hospital (27) · Bristol-Myers Squibb (24) · Nanfang Hospital, Southern Medical University (21) · Assembly Biosciences (17)

What is being tested here

Drugs under test in Hepatitis B, Chronic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Hepatitis B Virus Antisense Oligonucleotide AHB-1376111
Peginterferon alfa-2b5514
Tenofovir alafenamide4125
Entecavir31262
Neracorvir324
Sintilimab303
Bepirovirsen227
TVAX-008204
Envafolimab203
AHB-171202

Drug classes tested here Immune checkpoint inhibitors 6 open · Reverse transcriptase inhibitors 94

Coming up

9phase 3 studies under way
58studies finish main data collection within a year4 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 96 Hepatitis B, Chronic studies recruiting now, 33 (34%) set no upper age limit and 58 (60%) stop at 75 or younger. 11 (11%) take children under 18. 3 (3%) are for women only and 0 (0%) for men only; 13 (14%) take healthy volunteers.

Recruiting studies that take each age, of 96
AgeWomenMen
108 (8%)7 (7%)
1886 (90%)85 (89%)
3093 (97%)90 (94%)
4095 (99%)92 (96%)
5092 (96%)91 (95%)
6578 (81%)77 (80%)
7540 (42%)39 (41%)
8533 (34%)32 (33%)

Across all 895 studies, recruiting or not: 67% stop at 75 or younger and 47% at 65; 11% take children; 3% are for women only and 1% for men only; 12% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hepatitis B, Chronic studies take

Of 87 phase 2 interventional studies under Hepatitis B, Chronic, half reached primary completion within 23 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 116 mo6–27 · 81 studies15 mo5–26 · 73 studies—
Phase 223 mo16–41 · 87 studies22 mo15–39 · 75 studies—
Phase 333 mo21–47 · 24 studies——
Phase 443 mo30–64 · 63 studies—47 mo40–83 · 46 studies
Interventional, no phase44 mo21–121 · 42 studies——
Observational55 mo31–99 · 71 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Newly registered7

Show 2 more

Studies

Recruiting first, then most recently updated. Showing 50 of 895. Browse all 895 → or search them.